INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

352 studies · page 13 of 15

2015 / Randomized controlled trial

Low-dose creatine supplementation for one year did not alter bone or muscle outcomes.

Postmenopausal osteopenic women were randomized to receive 1 g/d of creatine (n = 56) or dextrose placebo (n = 53) for one year. Bone mineral density at the spine, hip sites, and total skeleton showed no significant differences between or within treatment arms. Similarly, creatine did not significantly change body composition, lean mass, timed-up-and-go performance, or timed-stands test scores.

Lobo DM, Tritto AC, da Silva LR, et al. Exp Gerontol, 2015. PMID 26192975

2015 / Randomized controlled trial (Phase III)

Adding blueberry juice to etanercept treatment improved response rates and reduced side effects in patients with juvenile idiopathic arthritis.

A phase III randomized trial evaluated 201 JIA patients assigned to etanercept alone (50 mg twice weekly), etanercept plus 50 ml blueberry juice daily (ETABJ), or etanercept plus placebo juice (ETAPJ). After a 6-month follow-up, ACR20, ACR50, and ACR70 scores were significantly higher in the ETABJ group than in the other two groups (P < 0.05). Symptoms and side effects—including mental diseases, optic neuritis, weight gain, infection, cutaneous vasculitis, diarrhea, uveitis, and pancytopenia—were significantly reduced or absent in the ETABJ group. Blueberries also decreased IL-1 alpha and beta levels while increasing IL1RA levels.

Zhong Y, Wang Y, Guo J, et al. Tohoku J Exp Med, 2015. PMID 26477692

2015 / Controlled trial with four parallel groups

Periodic fluid redistribution increased bone density during diminished muscular activity in male volunteers.

Forty male volunteers were divided into four equal groups: active controls, hypokinetic subjects (HKS), periodic fluid redistribution controls (PFRCS), and periodic fluid redistribution hypokinetic subjects (PFRHS). Bone density was measured over a 390-day pre-experimental and a 360-day experimental period. Bone density at lumbar vertebrae (L1-L4), ulna and radius, tarsal and metatarsal, and tibia and fibula increased (p<0.05) in the PFRHS group compared to the HKS group, whereas it decreased (p<0.05) in the HKS group compared to pre-experimental levels and other groups. Bone density improvements in the PFRCS group were much less than in the PFRHS group, while active controls showed no change.

Federenko YF, Charapakhin KP, Yaroshenko YN, et al. Indian J Physiol Pharmacol, 2015. PMID 26571991

2014 / Randomized controlled trial

In osteopenic postmenopausal women, 100 g/day of dried plum increased ulna and spine bone mineral density compared to dried apple over 1 year.

Osteopenic postmenopausal women (n=160) were randomized to consume either 100 g dried plum/d or 75 g dried apple/d for 1 year, with all participants receiving daily calcium (500 mg) and vitamin D (400 IU). Dried plum significantly increased the BMD of the ulna and spine compared with the dried apple control group. Compared to baseline, dried plum changed RANKL (+1.99% vs. +18.33%), OPG (+4.87% vs. -2.15%), and sclerostin (-1.12% vs. +3.78%) relative to control, though these biomarker percentage changes did not reach statistical significance (P <= 0.05).

Hooshmand S, Brisco JR, Arjmandi BH Br J Nutr, 2014. PMID 24780728

2014 / Open-label clinical pilot study

Consumption of dried apple peel powder for 12 weeks was associated with improved joint range of motion and enhanced serum antioxidant protection.

An open-label pilot study evaluated the effects of consuming 4.25 g of dried apple peel powder (DAPP) daily for 12 weeks in 12 healthy subjects with moderate loss of joint range of motion and chronic pain. Consumption of DAPP for 12 weeks was associated with improved ROM, pain reduction, and a statistically significant improvement in serum antioxidant protective status. In vitro assays demonstrated that DAPP inhibited COX-2 and lipoxygenase enzymes and reduced ROS formation in inflammatory polymorphonuclear cells.

Jensen GS, Attridge VL, Benson KF, et al. J Med Food, 2014. PMID 25271471

2014 / Randomized controlled trial

Calcium supplementation reduced bone resorption during pregnancy and early postpartum in Mexican women.

In a randomized trial of 670 pregnant Mexican women, taking 1,200 mg per day of calcium reduced urinary N-telopeptides by 15.8% compared to placebo (p < 0.001). Greater pill compliance led to larger reductions in bone resorption up to 22.1% (p < 0.001). Calcium also produced a lower ratio of bone resorption to formation at one month postpartum (p = 0.04).

Ettinger AS, Lamadrid-Figueroa H, Mercado-García A, et al. Nutr J, 2014. PMID 25511814

2013 / Randomized, double-blind, placebo-controlled trial

Potassium citrate supplementation for 24 months improved bone density, microarchitecture, and FRAX scores in healthy older adults.

In a randomized, double-blind, placebo-controlled trial, 201 healthy older adults without osteoporosis were assigned to 60 mEq of oral potassium citrate daily or placebo for 24 months alongside calcium and vitamin D. Potassium citrate increased lumbar spine areal BMD from baseline by 1.7 ± 1.5% net of placebo (95% CI 1.0-2.3, P < 0.001). Trabecular densities also increased at the nondominant tibia (1.3 ± 1.3%, P < 0.001) and nondominant radius (2.0 ± 2.0%, P < 0.001), alongside improvements in trabecular bone volume/tissue volume (0.9 ± 0.8%), thickness (1.5 ± 1.6%), and number (1.9 ± 1.8%, all P < 0.05). Potassium citrate also significantly decreased FRAX fracture prediction scores in both sexes.

Jehle S, Hulter HN, Krapf R J Clin Endocrinol Metab, 2013. PMID 23162100

2013 / Randomized crossover trial

Tart cherry juice did not significantly outperform placebo for knee osteoarthritis symptoms.

In a randomized crossover trial, 58 individuals with knee osteoarthritis drank two 8 oz bottles of tart cherry juice or placebo daily for 6 weeks, separated by a 1-week washout. WOMAC scores decreased significantly following cherry juice intake (P < 0.01) but not placebo (P = 0.46), though the difference between treatments was not significant (P = 0.16). Cherry juice lowered hsCRP relative to placebo (P < 0.01), but walking time and acetaminophen use did not differ between treatments.

Schumacher HR, Pullman-Mooar S, Gupta SR, et al. Osteoarthritis Cartilage, 2013. PMID 23727631

2013 / Randomized controlled trial follow-up

Calcium supplementation during pregnancy caused persistent lower maternal bone mineral content in follow-up.

In a follow-up of a randomized trial, 68 rural Gambian women with low calcium intake were evaluated approximately 5 years after lactation. Placebo recipients showed increased size-adjusted bone mineral content (SA-BMC) when non-pregnant and non-lactating (NPNL, P <= 0.001), whereas calcium recipients (1500 mg/d in pregnancy) did not. Lower SA-BMC persisted in the calcium group at NPNL (lumbar spine, -7.5%; total hip, -10.5%; whole body, -3.6%) and in a future lactation (all P <= 0.001).

Jarjou LM, Sawo Y, Goldberg GR, et al. Am J Clin Nutr, 2013. PMID 23902782

2012 / Cluster randomized controlled trial

Scheduled sunlight exposure did not reduce fall risk or resolve vitamin D deficiency.

A cluster randomized trial across 51 care facilities assigned 602 older adults (mean age 86.4 years) to daily early-morning sunlight, sunlight with calcium (600 mg/day), or control for one year. Overall adherence was low at a median of 26%, and intention-to-treat analysis showed no effect on fall risk (IRR 1.06; 95% CI, 0.76-1.48; P = 0.73). However, attending at least 130 sunlight sessions was linked to significantly fewer falls (IRR 0.52; 95% CI, 0.31-0.88).

Sambrook PN, Cameron ID, Chen JS, et al. Osteoporos Int, 2012. PMID 21369788

2012 / Randomized controlled trial

High-dose oral or injectable vitamin D improved pain and mobility in older adults.

A randomized trial assigned 120 elderly participants (mean age 70.1 years) to 300,000 IU of vitamin D or placebo administered orally or intramuscularly. At four weeks, both routes of vitamin D significantly reduced parathyroid hormone (P = 0.0001) and raised vitamin D levels (P = 0.0001 for injection, P = 0.004 for oral). Both treated groups showed significant reductions in pain scores, improved mobility, and enhanced physical functioning.

Sakalli H, Arslan D, Yucel AE Rheumatol Int, 2012. PMID 21556746

2012 / Randomized double-blind crossover trial and open-label extension

Curcumin dose may affect light-chain response and bone turnover in MGUS and SMM.

In a randomized, double-blind crossover study with 36 patients, participants received a 4g dose of curcumin or placebo for 3 months before crossing over, followed by an optional 8g open-label extension. Curcumin treatment decreased the free light-chain ratio and reduced the difference between clonal and nonclonal light chains. Urine DPYD, representing bone resorption, decreased with curcumin but rose with placebo, while serum creatinine tended to drop.

Golombick T, Diamond TH, Manoharan A, et al. Am J Hematol, 2012. PMID 22473809

2012 / Crossover trial

Potassium bicarbonate supplementation counteracted bed-rest-induced decreases in IL-2 levels without affecting other immune parameters in healthy males.

Seven healthy young males completed two 3-week periods of head-down bed rest, receiving 90 mmol potassium bicarbonate daily as a nutritional countermeasure in a crossover design. In one bed rest period, a significant decrease in IL-2, IFN-γ, and TNF-α production occurred after PHA stimulation, leading to a relative Th2-shift before rapid normalization. Dietary supplementation with potassium bicarbonate counteracted the decrease in IL-2 levels during bed rest, but showed no impact on other immunological parameters.

Kelsen J, Bartels LE, Dige A, et al. Cytokine, 2012. PMID 22595648

2012 / Randomized controlled trial

A ginger extract reduced osteoarthritic pain as effectively as diclofenac with better stomach mucosa outcomes in a randomized trial.

In a randomized controlled study, 43 patients with knee and hip osteoarthritis received either 340 mg daily of a ginger extract (n=21) or 100 mg daily of diclofenac (n=22) for 4 weeks, with both groups also receiving 1000 mg glucosamine daily. Both groups showed significantly lowered arthritic pain on standing and moving measured by VAS. The ginger group experienced slightly but significantly lowered SODA pain, no change in SODA dyspepsia, and significantly increased stomach mucosa levels of PGE1, PGE2, and PGF2α. In contrast, the diclofenac group showed increased SODA pain and dyspepsia, along with decreased mucosal prostaglandins and negative stomach mucosa degeneration.

Drozdov VN, Kim VA, Tkachenko EV, et al. J Altern Complement Med, 2012. PMID 22784345

2011 / Randomized controlled trial

Lycopene supplementation significantly reduced oxidative stress parameters and the bone resorption marker NTx in postmenopausal women.

Sixty postmenopausal women underwent a 1-month washout and were then randomized to regular tomato juice (30 mg lycopene/day), lycopene-rich tomato juice (70 mg/day), Lyc-O-Mato capsules (30 mg/day), or placebo capsules for 4 months. Participants receiving tomato juice or lycopene capsules were analyzed together as a lycopene-supplemented group. Compared to placebo, 4 months of lycopene supplementation significantly increased serum lycopene (p < 0.001) and total antioxidant capacity (p < 0.05). Lycopene also led to significant reductions in lipid peroxidation (p < 0.05 vs placebo change), protein oxidation (p < 0.005 vs placebo change), and the bone resorption marker NTx (p < 0.02 vs placebo change).

Mackinnon ES, Rao AV, Josse RG, et al. Osteoporos Int, 2011. PMID 20552330

2011 / Ex vivo study using serum from a randomized/controlled test-meal feeding trial

Serum taken 4 hours after consuming an almond meal reduced osteoclast formation, activity, and gene expression in vitro.

Human osteoclast precursors were cultured with 10% serum obtained from 14 healthy subjects at baseline and 4 hours after consuming 3 macronutrient-balanced test meals containing almonds (60 g), potatoes, or rice. Compared to baseline serum, serum obtained 4 hours after the almond meal reduced osteoclast formation by approximately 20%, TRAP activity by approximately 15%, calcium release by approximately 65%, and the expression of cathepsin K, receptor activator of nuclear factor kB, and matrix metalloproteinase-9 by 13% to 23%. No effects were observed with serum from the potato or rice meals.

Platt ID, Josse AR, Kendall CW, et al. Metabolism, 2011. PMID 20947104

2011 / Randomized crossover trial

High-protein diet raised calcium absorption and excretion without altering bone markers in women

In a randomized crossover trial of 16 postmenopausal women, a high-protein, high-acid-load diet (118 g/d protein) was compared to a low-protein, low-acid-load diet (61 g/d protein) for seven weeks each. The high-protein diet increased fractional calcium absorption (26.5% versus 22.3%, P < 0.05) and urinary calcium excretion (203 versus 156 mg/d, P = 0.005). Net calcium balance did not differ significantly between diets, and bone turnover biomarkers remained unchanged.

NANO counterpoint →

Cao JJ, Johnson LK, Hunt JR J Nutr, 2011. PMID 21248199

2011 / Before-after trial (one-month depletion)

A one-month lycopene-restricted diet significantly decreased antioxidant enzymes and increased the bone resorption marker NTx in postmenopausal women.

Twenty-three healthy postmenopausal women underwent a one-month dietary lycopene-depletion period to assess effects on oxidative stress and bone turnover markers. Dietary restriction led to significant reductions in serum lycopene (p < 0.0001), lutein/zeaxanthin (p < 0.01), and α-/β-carotene (p < 0.05). Catalase and superoxide dismutase were significantly depressed (p < 0.05 and p < 0.005, respectively), glutathione peroxidase increased (p < 0.01), lipid and protein oxidation increases were not significant, and the bone resorption marker NTx significantly increased (p < 0.05).

Mackinnon ES, Rao AV, Rao LG J Nutr Health Aging, 2011. PMID 21365167

2011 / Randomized, double-blind, placebo-controlled pilot trial

Chondroitin sulphate significantly reduced cartilage volume loss starting at 6 months and bone marrow lesions at 12 months in knee osteoarthritis patients.

In a pilot multicentre trial, 69 patients with primary knee osteoarthritis and clinical signs of synovitis were randomised to 800 mg chondroitin sulphate (CS) or placebo once daily for 6 months, followed by a 6-month open-label phase where all patients received CS 800 mg daily. The CS group demonstrated significantly less cartilage volume loss than placebo at 6 months for the global knee (p=0.030), lateral compartment (p=0.015), and tibial plateaus (p=0.002), with significance maintained at 12 months. Significantly lower bone marrow lesion scores occurred in the CS group at 12 months in the lateral compartment (p=0.035) and lateral femoral condyle (p=0.044), while disease symptoms were similar between groups.

Wildi LM, Raynauld JP, Martel-Pelletier J, et al. Ann Rheum Dis, 2011. PMID 21367761

2011 / Open-label clinical pilot study

Açai-fortified fruit juice consumption was followed by reduced pain, improved range of motion, and increased serum antioxidant status in a pilot study.

In an open-label pilot study, 14 participants with pain-associated range of motion limitations consumed 120 mL of an açai-fortified fruit and berry juice blend daily for 12 weeks. Juice consumption resulted in significant pain reduction, improved range of motion measures, and improvement in activities of daily living. Serum antioxidant status improved within 2 weeks and continued through 12 weeks (P < .01), while reductions in C-reactive protein did not reach statistical significance and lipid peroxidation decreased mildly.

Jensen GS, Ager DM, Redman KA, et al. J Med Food, 2011. PMID 21470042

2011 / Randomized controlled trial

Dried plum intake significantly increased ulna and spine bone mineral density compared with dried apple in postmenopausal women.

In a randomized trial, 160 osteopenic postmenopausal women were assigned to receive either 100 g/day of dried plum or dried apple as a comparative control for 12 months, with all participants receiving daily calcium (500 mg) and vitamin D (400 IU). Dried plum significantly increased the BMD of the ulna and spine compared with dried apple. Additionally, only the dried plum group showed significant decreases from baseline in serum bone turnover markers, including bone-specific alkaline phosphatase and tartrate-resistant acid phosphatase-5b.

Hooshmand S, Chai SC, Saadat RL, et al. Br J Nutr, 2011. PMID 21736808

2010 / Randomized controlled trial

Brief, daily high-impact hopping exercise significantly increased femoral neck bone mineral density in premenopausal women.

Premenopausal women were randomly assigned to perform 50 multidirectional hops on one leg 0, 2, 4, or 7 days per week for 6 months. Adjusted femoral neck BMD changes differed between groups (p=0.015), showing changes of -0.3% (-1.2 to 0.6), 0.0% (-1.0 to 1.0), 0.9% (-0.1 to 2.0), and 1.8% (0.8 to 2.8) for 0, 2, 4, and 7 days per week, respectively. While an overall exercise effect was noted across hip sites (p=0.048), changes did not differ significantly between the upper neck, lower neck, and trochanter (p=0.439).

Bailey CA, Brooke-Wavell K Bone, 2010. PMID 20004758

2010 / Randomised single-blind acute cross-over trial

Calcium absorption from soymilk fortified with a proprietary calcium phosphate was comparable to that from cow's milk in osteopenic post-menopausal women.

A randomized single-blind acute crossover study evaluated calcium absorption from soymilk fortified with a proprietary phosphate of calcium compared with cow's milk in 12 osteopenic post-menopausal women. Participants consumed 20 mL of test milk labeled with 185 kBq of 45Ca in 44 mg of calcium carrier to determine the hourly fractional calcium absorption rate (alpha). The mean hourly fractional calcium absorption from fortified soymilk was comparable to that of cow's milk (alpha = 0.65 +/- 0.19 vs. alpha = 0.66 +/- 0.22, p > 0.05).

Tang AL, Walker KZ, Wilcox G, et al. Asia Pac J Clin Nutr, 2010. PMID 20460239

2010 / Randomized controlled trial

Annual high-dose oral vitamin D increased falls and fractures in older women.

A randomized trial assigned 2,256 community-dwelling women aged 70 years or older at high fracture risk to an annual dose of 500,000 IU cholecalciferol or placebo for 3 to 5 years. The vitamin D group experienced more fractures (171 vs 135; incidence RR 1.26, 95% CI 1.00-1.59, P = 0.047) and more falls (incidence RR 1.15, 95% CI 1.02-1.30, P = 0.03).

Sanders KM, Stuart AL, Williamson EJ, et al. JAMA, 2010. PMID 20460620